Long-term oxygen treatment in chronic obstructive pulmonary disease: recommendations for future research: An NHLBI workshop report

American Journal of Respiratory and Critical Care Medicine

Volumn 174, Issue 4, 2006, Pages 373-378

  Croxton, Thomas L ^a   Bailey, William C ^b  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b NONE

Author keywords

Chronic bronchitis; Hypoxia, therapy; Lung diseases, obstructive; Oxygen inhalation therapy; Pulmonary emphysema

Indexed keywords

OXYGEN;

AMBULATORY CARE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; EXERCISE; FATTY ACID DESATURATION; FLOW RATE; HUMAN; HYPOXEMIA; LONG TERM CARE; LUNG DISEASE; MEDICAL RESEARCH; OUTCOME ASSESSMENT; PATIENT CARE; PHENOTYPE; PRESCRIPTION; PRIORITY JOURNAL; SLEEP; SLEEP APNEA SYNDROME;

ANOXEMIA; CLINICAL TRIALS; HUMANS; MEDICARE; OXYGEN INHALATION THERAPY; PATIENT SELECTION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESEARCH; UNITED STATES;

EID: 33747127127     PISSN: 1073449X     EISSN: 1073449X     Source Type: Journal    
DOI: 10.1164/rccm.200507-1161WS     Document Type: Conference Paper

References (44)

1. Mannino DM, Homa DM, Akinbami LJ, Ford ES, Redd SC. Chronic obstructive pulmonary disease surveillance: United States, 1971-2000. MMWR CDC Surveill Summ 2002;51:1-16.
2. Nichol KL, Baken L, Nelson A. Relation between influenza vaccination and outpatient visits, hospitalization, and mortality in elderly persons with chronic lung disease. Ann Intern Med 1999;130:397-403.
3. Nichol KL, Baken L, Wuorenma J, Nelson A. The health and economic benefits associated with pneumococcal vaccination of elderly persons with chronic lung disease. Arch Intern Med 1999;159:2437-2442.
4. Ram FSF, Picot J, Lightowler J, Wedzicha JA. Non-invasive positive pressure ventilation for treatment of respiratory failure due to exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2004;1:CD004104.
5. National Emphysema Treatment Trial Research Group. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med 2003;348:2059-2073.
6. Nocturnal Oxygen Therapy Trial Group. Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Ann Intern Med 1980;93:391-398.
7. Medical Research Council Working Party. Long-term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Lancet 1981;1:681-686.
8. Gorecka D, Sliwinski P, Zielinski J. Adherence to entry criteria and one year experience of long-term oxygen therapy in Poland. Eur Respir J 1992;5:848-852.
9. Ström K. Survival of patients with chronic obstructive pulmonary disease receiving long-term domiciliary oxygen therapy. Am Rev Respir Dis 1993;147:585-591.
10. Dallari R, Barozzi G, Pinelli G, Merighi V, Grandi P, Manzotti M, Tartoni PL. Predictors of survival in subjects with chronic obstructive pulmonary disease treated with long-term oxygen therapy. Respiration (Herrlisheim) 1994;61:8-13.
11. Dubois P, Jamart J, Machiels J, Smeets F, Lulling J. Prognosis of severely hypoxemic patients receiving long-term oxygen therapy. Chest 1994;105:469-474.
12. Aida A, Miyamoto K, Nishimura M, Aiba M, Kira S, Kawakami Y; Respiratory Failure Research Group in Japan. Prognostic value of hypercapnia in patients with chronic respiratory failure during long-term oxygen therapy. Am J Respir Crit Care Med 1998;158:188-193.
13. Zieliński J, Tobiasz M, Hawryłkiewicz I, Śliwiński P, Pałasiewicz G. Effects of long-term oxygen therapy on pulmonary hemodynamics in COPD patients: a 6-year prospective study. Chest 1998;113:65-70.
14. Mitchell GS, Baker TL, Nanda SA, Fuller DD, Zabka AG, Hodgeman BA, Bavis RW, Mack KJ, Olson EB Jr. Invited review: intermittent hypoxia and respiratory plasticity. J Appl Physiol 2001;90:2466-2475.
15. Raj U, Shimoda L. Oxygen-dependent signaling in pulmonary vascular smooth muscle. Am J Physiol Lung Cell Mol Physiol 2002;283:L671-L677.
16. 2 homeostasis by hypoxia-inducible factor 1. Annu Rev Cell Dev Biol 1999;15:551-578.
17. O'Donohue WJ Jr. Effect of oxygen therapy on increasing arterial oxygen tension in hypoxemic patients with stable chronic obstructive pulmonary disease while breathing ambient air. Chest 1991;100:968-972.
18. Weitzenblum E, Sautegeau A, Ehrhart M, Mammosser M, Pelletier A. Long-term oxygen therapy can reverse the progression of pulmonary hypertension in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1985;131:493-498.
19. Stewart BN, Hood CI, Block AJ. Long-term results of continuous oxygen therapy at sea level. Chest 1975;68:486-492.
20. Heaton RK, Grant I, McSweeny AJ, Adams KM, Petty TL. Psychological effects of continuous and nocturnal oxygen therapy in hypoxemic chronic obstructive pulmonary disease. Arch Intern Med 1983;143:1941-1947.
21. Weitzenblum E, Oswald M, Apprill M, Ratomaharo J, Kessler R. Evolution of physiological variables in patients with chronic obstructive pulmonary disease before and during long-term oxygen therapy. Respiration (Herrlisheim) 1991;58:126-131.
22. Borak J, Sliwinski P, Tobiasz M, Zielinski J. Psychological status of COPD patients before and after one year of long-term oxygen therapy. Monaldi Arch Chest Dis 1996;51:7-11.
23. Clini E, Vitacca M, Foglio K, Simoni P, Ambrosino N. Long-term home care programmes may reduce hospital admissions in COPD with chronic hypercapnia. Eur Respir J 1996;9:1605-1610.
24. Okubadejo AA, Paul EA, Jones PW, Wedzicha JA. Does long-term oxygen therapy affect quality of life in patients with chronic obstructive pulmonary disease and severe hypoxaemia? Eur Respir J 1996;9:2335-2339.
25. Ringbaek TJ, Viskum K, Lange P. Does long-term oxygen therapy reduce hospitalisation in hypoxaemic chronic obstructive pulmonary disease? Eur Respir J 2002;20:38-42.
26. Eaton T, Lewis C, Young P, Kennedy Y, Garrett JE, Kolbe J. Longterm oxygen therapy improves health-related quality of life. Respir Med 2004;98:285-293.
27. Haidl P, Clement C, Wiese C, Dellweg D, Köhler D. Long-term oxygen therapy stops the natural decline of endurance in COPD patients with reversible hypercapnia. Respiration (Herrlisheim) 2004;71:342-347.
28. Górecka D, Gorselak K, Śliwiński P, Tobiasz M, Zieliński J. Effect of long term oxygen therapy on survival in patients with chronic obstructive pulmonary disease with moderate hypoxaemia. Thorax 1997;52:674-679.
29. Chaouat A, Weitzenblum E, Kessler R, Charpentier C, Ehrhart M, Schott R, Levi-Valensi P, Zielinski J, Delaunois L, Cornudella R, et al. A randomized trial of nocturnal oxygen therapy in chronic obstructive pulmonary disease patients. Eur Respir J 1999;14:1002-1008.
30. Chow LC, Wright KW, Sola A; CSMC Oxygen Administration Study Group. Can changes in clinical practice decrease the incidence of severe retinopathy of prematurity in very low birth weight infants? Pediatrics 2003;111:339-345.
31. McColm JR, Cunningham S, Wade J, Sedowofia K, Gellen B, Sharma T, McIntosh N, Fleck BW. Hypoxic oxygen fluctuations produce less severe retinopathy that hyperoxic fluctuations in a rat model of retinopathy of prematurity. Pediatr Res 2004;55:107-113.
32. Loiseaux-Meunier MN, Bedu M, Gentou C, Pepin D, Coudert J, Caillaud D. Oxygen toxicity: simultaneous measurement of pentane and malondialdehyde in humans exposed to hyperoxia. Biomed Pharmacother 2001;55:163-169.
33. 2 production in rats. Exp Lung Res 2003;29:585-592.
34. Carpagnano GE, Kharitonov SA, Foschino-Barbaro MP, Resta O, Gramiccioni E, Barnes PJ. Supplementary oxygen in healthy subjects and those with COPD increases oxidative stress and airway inflammation. Thorax 2004;59:1016-1019.
35. MacNee W. Oxidative stress and lung inflammation in airways disease. Eur J Pharmacol 2001;429:195-207.
36. Oba Y, Salzman GA, Willsie SK. Reevaluation of continuous oxygen therapy after initial prescription in patients with chronic obstructive pulmonary disease. Respir Care 2000;45:401-406.
37. Centers for Medicare and Medicaid Services. Medicare Coverage Database, NCD Chapter 240.2. Available from: http://www.cms.hhs.gov/mcd/ index_chapter_list.asp (accessed July 6, 2006).
38. Selinger SR, Kennedy TP, Buescher P, Terry P, Parham W, Gofreed D, Medinger A, Spagnolo SV, Michael JR. Effects of removing oxygen from patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1987;136:85-91.
39. Lama VN, Flaherty KR, Toews GB, Colby TV, Travis WD, Long Q, Murray S, Kazerooni EA, Gross BH, Lynch JP III, et al. Prognostic value of desaturation during a 6-minute walk test in idiopathic interstitial pneumonia. Am J Respir Crit Care Med 2003;168:1084-1090.
40. O'Donnell DE, D'Arsigny C, Webb KA. Effects of hyperoxia on ventilatory limitation during exercise in advanced chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001;163:892-898.
41. Fletcher EC, Levin DC. Cardiopulmonary hemodynamics during sleep in subjects with chronic obstructive pulmonary disease: the effect of short- and long-term oxygen. Chest 1984;85:6-14.
42. 2 >60 mm Hg with and without nocturnal oxyhemoglobin desaturation. Chest 1992;101:649-655.
43. Neri M, Melani AS, Miorelli AM, Zanchetta D, Bertocco E, Cinti C, Canessa PA, Sestini P, for the Educational Study Group of the Italian Association of Hospital Pulmonologists (AIPO). Long-term oxygen therapy in chronic respiratory failure: a Multicenter Italian Study on Oxygen Therapy Adherence (MISOTA). Respir Med 2006;100:795-806.
44. Muehlberger T, Smith MA, Wong L. Domiciliary oxygen and smoking: an explosive combination. Burns 1998;24:658-660.